CP
Clayton Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Sell |
18,372
-1,867
| -9% | -$347K | 2.87% | 13 |
|
|
2025
Q1 | $4.24M | Buy |
20,239
+260
| +1% | +$54.5K | 3.69% | 9 |
|
|
2024
Q4 | $3.55M | Sell |
19,979
-101
| -0.5% | -$17.9K | 2.46% | 18 |
|
|
2024
Q3 | $3.97M | Sell |
20,080
-164
| -0.8% | -$32.4K | 2.86% | 13 |
|
|
2024
Q2 | $3.47M | Sell |
20,244
-227
| -1% | -$38.9K | 2.79% | 15 |
|
|
2024
Q1 | $3.73M | Sell |
20,471
-3,913
| -16% | -$713K | 3.17% | 11 |
|
|
2023
Q4 | $3.78M | Buy |
24,384
+19
| +0.1% | +$2.94K | 3.06% | 14 |
|
|
2023
Q3 | $3.63M | Buy |
24,365
+584
| +2% | +$87.1K | 3.09% | 14 |
|
|
2023
Q2 | $3.2M | Sell |
23,781
-157
| -0.7% | -$21.2K | 2.77% | 14 |
|
|
2023
Q1 | $3.82M | Buy |
23,938
+68
| +0.3% | +$10.8K | 3.71% | 9 |
|
|
2022
Q4 | $3.86M | Buy |
23,870
+542
| +2% | +$87.6K | 3.65% | 10 |
|
|
2022
Q3 | $3.13M | Buy |
23,328
+78
| +0.3% | +$10.5K | 3.53% | 9 |
|
|
2022
Q2 | $3.56M | Sell |
23,250
-44
| -0.2% | -$6.74K | 3.84% | 10 |
|
|
2022
Q1 | $3.78M | Buy |
23,294
+807
| +4% | +$131K | 3.18% | 12 |
|
|
2021
Q4 | $3.05M | Buy |
22,487
+330
| +1% | +$44.7K | 2.65% | 13 |
|
|
2021
Q3 | $2.39M | Sell |
22,157
-8
| -0% | -$863 | 2.29% | 21 |
|
|
2021
Q2 | $2.5M | Buy |
22,165
+772
| +4% | +$87K | 2.1% | 21 |
|
|
2021
Q1 | $2.32M | Buy |
+21,393
| New | +$2.32M | 2.24% | 19 |
|